Evidence map›Paper›PMID 28804596›Full record

ArticleJournal of extracellular vesicles2017

Characterisation of tumour-derived microvesicles in cancer patients' blood and correlation with clinical outcome.

Kerstin Menck, Annalen Bleckmann, Astrid Wachter, Bianca Hennies, Lena Ries, Matthias Schulz, Marko Balkenhol, Tobias Pukrop, Bawarjan Schatlo, Ulrike Rost and 3 more

Open access · goldAbstract read
In one paragraph

Article in Journal of extracellular vesicles, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 3 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 3 syntheses or guidelines pooled it, 111 citations in OpenAlex.

  1. Prognostic value of extracellular vesicles in colorectal cancer: a systematic review and meta-analysis.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Kerstin MenckDepartment of Haematology/Medical Oncology, University Medical Centre Göttingen, Göttingen, Germany.ORCID 0000-0002-8188-0163
Annalen BleckmannDepartment of Haematology/Medical Oncology, University Medical Centre Göttingen, Göttingen, Germany.
Astrid WachterDepartment of Medical Statistics, University Medical Centre Göttingen, Göttingen, Germany.ORCID 0000-0002-4611-4260
Bianca HenniesDepartment of Haematology/Medical Oncology, University Medical Centre Göttingen, Göttingen, Germany.
Lena RiesDepartment of Haematology/Medical Oncology, University Medical Centre Göttingen, Göttingen, Germany.
Matthias SchulzDepartment of Haematology/Medical Oncology, University Medical Centre Göttingen, Göttingen, Germany.ORCID 0000-0001-8884-6008
Marko BalkenholComprehensive Cancer Centre, University Medical Centre Göttingen, Göttingen, Germany.
Tobias PukropDepartment of Haematology/Medical Oncology, University Medical Centre Göttingen, Göttingen, Germany.
Bawarjan SchatloDepartment of Neurosurgery, University Medical Centre Göttingen, Göttingen, Germany.ORCID 0000-0002-9221-0843
Ulrike RostInstitute for Organic and Biomolecular Chemistry, University of Göttingen, Göttingen, Germany.
Dirk WenzelDepartment of Structural Dynamics, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany.
Florian KlemmDepartment of Haematology/Medical Oncology, University Medical Centre Göttingen, Göttingen, Germany.
Claudia BinderDepartment of Haematology/Medical Oncology, University Medical Centre Göttingen, Göttingen, Germany.
Max Planck Institute for Biophysical Chemistry · DEUniversity of Göttingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To evaluate whether tumour-derived microvesicles (T-MV), originating from the plasma membrane, represent suitable cancer biomarkers, we isolated MV from peripheral blood samples of cancer patients with locally advanced and/or metastatic solid tumours (

Indexed as

biomarkerCancerEMMPRINextracellular vesiclesmicrovesiclestumour invasion

Identifiers

PMID28804596
PMCPMC5533131
OpenAlexW2737070451

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.